explore -WSS

explore

author：hotspot 2025-09-30 22:28:04 - browse：6142

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Late stage cancers on the rise after pandemic delayed screenings

WSS

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Group behind ProMed defends move to subscription

Study links childhood stress with decline in older age

How to ethically and practically extend health care to all

The a glaring gap in research on serious mental illness and primary care

Where are patients getting their prescriptions for GLP

focus

explore

explore

Moonlake's readout produced a cash windfall. Risks remain

CDC recommends RSV monoclonal antibody for infants

ChatGPT in medicine: STAT answers readers' burning questions

The a glaring gap in research on serious mental illness and primary care

Continuity nursing helped my family in our darkest PICU moments

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Peter Hotez and the public health issue of online harassment

An innovative path out of biotech’s “valley of death”

Drug repurposing or repositioning? The language matters

CDC recommends RSV monoclonal antibody for infants

leisure time

Chris Christie meets with Zelenskyy during Ukraine trip

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

CDC recommends RSV monoclonal antibody for infants

TB outbreak tied to bone grafts underscores testing shortcomings

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Biotech startup Celsius cuts 75% of staff ahead of first trial start

entertainment

hotspot

hotspot

leisure time